Allan Jonathan (CIK 0001966716)

Latest company ownership

STOK - Stoke Therapeutics, Inc.

Role: GENERAL COUNSEL & CORP SEC

Shares held

36,545

Last filed at

Dec 3, 2025

Confidence Score

2.9

2025Q4

Confidence Score History

2023Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 8, 2025	Dec 10, 2025	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	10.0	-3,978	-25.16%	✓	$128.4K
Dec 3, 2025	Dec 5, 2025	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	7.5	-9,803	-38.28%	✓	$306.3K
Dec 1, 2025	Dec 3, 2025	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	42.5	-4,576	-18.92%	✗	$138.3K
Oct 3, 2025	Oct 7, 2025	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	7.5	-10,000	-45.81%	✓	$250.7K
Aug 29, 2025	Sep 3, 2025	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	7.5	-22,117	-29.07%	✓	$444.8K
Aug 18, 2025	Aug 20, 2025	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	46.3	-1,683	-6.57%	✗	$30.7K
Aug 13, 2025	Aug 15, 2025	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	10.0	-13,712	-41.12%	✓	$205.7K
Mar 18, 2025	Mar 20, 2025	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	46.3	-4,211	-11.77%	✗	$35.7K
Dec 9, 2024	Dec 11, 2024	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	10.0	-13,666	-38.89%	✓	$186K
Dec 6, 2024	Dec 10, 2024	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	42.5	-9,696	-21.62%	✗	$123.9K
May 20, 2024	May 22, 2024	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	10.0	-8,599	-76.80%	✓	$129.3K
Mar 28, 2024	Apr 1, 2024	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	10.0	-5,126	-66.36%	✓	$67.7K
Mar 15, 2024	Mar 19, 2024	Stoke Therapeutics, Inc.	GENERAL COUNSEL & CORP SEC	Sell	46.3	-2,349	-23.32%	✗	$14.3K
Jun 21, 2023	Jun 23, 2023	Stoke Therapeutics, Inc.	General Counsel & Corp Sec	Sell	13.8	-1,948	-100.00%	✓	$26.3K